Evidence map›Paper›PMID 41430125›Full record

ArticleBMC primary care2025

Knowledge, attitude, and practice towards insulin therapy in type 2 diabetes: an insight from Ethiopian context.

Biniyam Woya Sheno, Ahmed Reja Goush, Meiraf Daniel Meshesha

Abstract read
In one paragraph

Article in BMC primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Biniyam Woya ShenoDepartment of Internal Medicine, Dilla University, Dilla, Ethiopia. biniyamw2@gmail.com.
Ahmed Reja GoushDepartment of Internal Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
Meiraf Daniel MesheshaDepartment of Internal Medicine, Dilla University, Dilla, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAs type 2 diabetes is a growing health problem worldwide, targeting an early treatment and intensification of therapy will decrease the associated morbidity and mortality as evidenced by large trials. Insulin therapy is delayed in this group of patients and multiple physician and patient factors have been mentioned in different settings.

methodsA cross-sectional, hospital-based, quantitative study was conducted among 221 people with type 2 diabetes attending Tikur Anbessa Specialized Hospital endocrine clinic and 122 physicians who were working at this clinic. The study was conducted from July 1, 2020 to September 30, 2020.

resultAbout 31.5% of the patients reported taking insulin at the prescribed time was difficult while this difficulty was mentioned by 76% of the physicians. Hypoglycemia was found to be one of the most feared parts of having diabetes in 81.1% of patients on Insulin therapy. 87% of physicians and 76.6% of patients think insulin-treated diabetes controls life while. 56% of patients on non insulin therapy know nothing about insulin therapy. 23% of patients said they will not accept insulin therapy the top reason being they will be afraid of insulin injection because they think it will be painful.

conclusionPhysicians tend to overestimate the difficulty of insulin injection preparation and dose adjustment was feared for the risk of hypoglycemia when starting insulin therapy. More than half of the patients who did not initiate insulin therapy know nothing about insulin therapy and this needs to improve. Even if patients not on insulin therapy overestimate insulin needle phobia and injection pain those who are already on insulin disagreed with them.

Indexed as

Diabetes Mellitus, Type 2Health Knowledge, Attitudes, PracticeHypoglycemic AgentsInsulinAdultAgedCross-Sectional StudiesEthiopiaFemaleHumansHypoglycemiaMaleMiddle AgedHypoglycemic AgentsInsulinInsulin treatmentTreatment inertiaType 2 DM

Identifiers

PMID41430125
PMCPMC12723896

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.